What is Celcuity Inc (CELC)?
Celcuity Inc is a biotechnology company engaged in the development of diagnostic tests aimed at improving cancer treatment. The company focuses on leveraging molecular profiling and biomarker analysis to identify patients who may benefit from targeted therapies. Celcuity Inc’s diagnostic solutions are designed to support precision medicine by providing insights into tumor biology and treatment responsiveness. The company’s research and development efforts involve collaboration with clinical and scientific partners to validate and commercialize its diagnostic platforms. Operating within the healthcare and life sciences sector, Celcuity Inc addresses the need for personalized approaches to cancer care. Its technologies contribute to informed clinical decision-making and the optimization of therapeutic outcomes for patients.
Celcuity Inc Stock Price Today: Live Overview
The price today is shaped by intraday activity, with Bright Minds Biosciences Inc at $116.12. The session's price has moved from $106.45 to $117.86, with a daily change of +4.3297%.
FAQ: Celcuity Inc (CELC)
What is the current price of CELC stock?
The current price is $116.12.
Does CELC pay dividends?
No dividends are paid.
Does CELC have a formal corporate presence or regional headquarters in the UAE?
Celcuity Inc does not have an official regional office or subsidiary in the UAE and operates through partners.
What is CELC best known for?
Celcuity Inc is most famous for its work in precision oncology and cancer diagnostics.
What assets are typically shown together with CELC?
Commonly shown alongside CELC: Stora Enso, Sportradar Group AG, Capital Group Global Growth Equity ETF
Latest shares articles



